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CYCLIC 3' ,5'-NUCLEOTIDE PHOSPHODIESTERASE IN RAT SKIN 
II. BIOCHEMICAL CHARACTERIZATION* 
L. E. KING , JR., M.D., PH.D. , S. S. SoLoMoN, M.D., AND K. HASHIMOTO, M.D . 
Divisions of Dermatology and Endocrinology, Departments of Medicine and Anatomy, Veterans Administration 
Hospital and University of Tennessee, Memphis, Tennessee 
The biochemical characteristics of cyclic 3',5' -nucleotide phosphodiesterase were studied 
in homogenates of male albino rat skin using preparations which were predominantly 
epidermal. Enzymatic activity was detected in both the particulate and soluble fractions of 
these skin homogenates. Two kinetically distinct phosphodiesterase (PDE) activities were 
detected in the soluble fraction (100,000 x g supernatant). This 100,000 x g supernatant 
contains at least two distinct protein bands that hydrolyze cyclic AMP as demonstrated by 
gel electrophoresis. Divalent cations (Mg++ or Mn ++ ) and 2-mercaptoethanol were required 
for maximal enzymatic activity. Epinephrine, dibutyryl cyclic AMP, and methylxanthines 
inhibited while imidazole and histamine phosphate stimulated the cyclic AMP phosphodies-
terase activity at high and low cyclic AMP concentrations. Cyclic GMP competitively 
inhibited hydrolysis of low, but not high , concentrations of cyclic AMP . Hydrocortisone 
phosphate in pharmacologic concentrations blocked PDE denaturation by heat. These 
studies indicate that there are complex interrelationships between cyclic nucleotides and 
PDE in rat skin. 
Cyclic nucleotide phosphodiesterase (PDE) is 
the only known hydrolytic enzyme that degrades 
cyclic 3', 5' -adenosine monophosphate (cyclic 
AMP) [1-5 ]. Recent evidence suggests that the 
control of cyclic AMP and cyclic GMP levels may 
be important in regulating growth and function in 
skin and other tissues [6-9 ). Although PDE has 
been demonstrated biochemically [9- 11] and his-
tochemically in the skin [12], little is known of 
specific factors controlling its activity in skin or 
other tissues. Several possible mechanisms have 
been suggested: specific protein activation [4, 13~ 
14 ], subcellular compartmentation [15, 16 ], isoen-
zymes [17 ], or allosteric enzymes [18 ]. 
Since all of these mechanisms may contribute to 
the control of levels of cyclic nucleotides in skin, we 
have begun studies on the different possibilities. 
The subcellular localization of PDE in rat skin has 
been reported elsewhere [12 ]. We, therefore, wish 
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to report our biochemical studies of PDE m rat 
epidermis. 
MATERIALS AND METHODS 
Chemicals. Cyclic [8- 3H ]AMP (sp act 16.3 Ci/mmole) 
was obtained from Schwarz/Mann, Orangeburg, N.Y. 
Prior to use , the cyclic [8- 3H ]AMP was repurified by 
passage through a Dowex 50W -8, 200- 400 mesh cation 
exchange column [19 ]. All unlabeled nucleotides, hor-
mones , and the snake venom, Ophiophagus hannah, 
containing 5' -nucleotidase activity were purchased from 
Sigma Chemical Co., St. Louis , Missouri except as noted 
in the footnotes to Tables I and II . All other chemicals 
were reagent grade and were obtained commercially. 
Preparation of PDE. Adult male albino rats (200-300 
gm) were obtained from Boltzmann Co. , Madison, Wis-
consin. These rats were maintained on a diet of Purina 
Laboratory chow and fed ad libitum . After decapitation , 
the hair was clipped, and the back skin and foot pads 
dissected free of underlying subcutaneous tissue. The· 
skil\ was then stretched and fixed on cork plates with the 
epidermis facing downward. The dermis was removed by 
scraping. The remaining epidermis was then rinsed with 
iced saline, blotted dry, and weighed . The percent dermal 
contamination of the foot pads and the back skin was less 
than 10% and 40%, respectively , based on visual estima-
tion and 14C labeling of dermal collagen (unpublished 
observations). After dicing with scissors and razor blades, · 
the epidermis was homogenized using a method previ-
ously reported [20]. One gram of rat epidermis was 
homogenized in 3 ml of glass-distilled water using a 
Waring blender and a Potter-Elvehjem homogenizer. 
The resultant homogenate was sonicated (Branson Son-
nifer, setting #5) at - 4°C for 3 times (10 sec each) with 
1-min cooling intervals. After rapid freezing and thawing, 
the homogenate was centrifuged in 0.25 M sucrose at 
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1,000, 10,000, 30,000, or 100,000 x g at 0°C for 30 min. 
Free fat was removed by aspiration and the supernatant 
and precipitate separated. Both supernatant and precipi-
tate fractions were dialyzed in a large volume (4.25liters) 
against 20 mM Tris- HCl buffer, pH 7.5, with 5 diffusate 
changes during a 24-hr period . The solution was then 
divided into 10-ml aliquots which were frozen and stored 
at - l0°C. Preparations from rat brain containing PDE 
activity in the 100,000 x g supernatant were prepared by 
methods previously described [19]. Protein determina-
tions on the various fractions were made using the 
method of Lowry et al [21 ]. At biweekly intervals, the 
PDE activity of the preparations was checked and found 
to be stable under these storage conditions. 
Enzy me assay methods. The PDE assay method used 
was a slight modification [20] of the two-step radioiso-
tope method of Thompson and Appleman [17 ]. Each 
incubation mixture of 0.5 ml contained 0.1 ml of PDE 
enzyme preparation from the foot pads unless otherwise 
indicated, 3.5 mM Tris- HCl (pH 7.4, 8.0), 5 mM Mg++ , 
3.75 mM 2-mercaptoethanol, cyclic [8- 3H]AMP, and the 
concentrations of cyclic AMP or other cyclic nucleotides 
as indicated . 
To study the effects of heavy metals , inhibitors and 
stimulators of PDE, and hormonal effects, the test agents 
were incubated with the broken cell preparations from 
both foot pad and back skin using the methods listed in 
each figure's legend. PDE activity after polyacrylamide 
gel electrophoresis was determined by using the method 
of Goren et al [22] with only minor modifications. The 
100,000 x g supernatant samples used were 0.1 ml of 2 or 
4 mg per ml solution. The cyclic AMP concentrations 
used were 0.2 mM or 2.5 mM. After PDE localization by 
the gel staining method, some gels were fixed and then 
stained with Coomassie blue to determine the positions of 
the corresponding protein bands. Other gels were cut into 
1.5-mm slices and assayed for PDE activity using the 
cyclic [8- 3H ]AMP method to determine the specificity of 
the gel staining method . 
RESULTS 
Subcellular distribution of rat skin homogenate 
PDE (Fig. 1). When rat skin was homogenized in 
0.25 M sucrose and fractionated by differential 
centrifugation, PDE activity was distributed 
among several fractions. Sixty-five percent of the 
total PDE activity was found in the 100,000 x g 
supernatant. The remaining 35% of the activity 
was equally divided among membrane, mitochon-
dria, and microsomal fractions. All subsequent 
biochemical studies were done on the 100,000 x g 
supernatant fraction. 
Enzy me concentration, incubation time, and pH 
optima (Figs. 2A- C). The rate of hydrolysis of 
cyclic AMP was directly proportional to the pro-
tein concentration of the preparation (Fig. 2A) and 
to the time of incubation (Fig. 2B) over a 45-min 
period. The optimal pH was between pH 7.4 and 
8.0 (Fig. 2C). The PDE enzymatic activity was de-
stroyed by heating at temperatures greater than 
80°C for 3 min. The specific activity of rat skin 
PDE under optimal conditions was 0.1 J,Lm per mg 
protein per min which was approximately 10% of 
the activity of PDE in control rat brain prepara-
































Total 1,000 10,000 100,000 100,000 
Activity XO XQ XQ XQ 
ppt. ppt. ppt. sup. 
FIG. 1. Subcellular distribution of rat skin PDE. The 
PDE activity of rat skin homogenates after differential 
centrifugation in 0.25 M sucrose is shown (n = 3). The 
activity of the homogenates (0. 1 mg/ml) was measured 
using a 10-min incubation at 30°C at cyclic AMP 
concentrations ranging from 1 J.LM to 3 mM. 
at - l0°C and the skin PDE activity was remarka-
bly stable at - l0°C for at least 6 months. 
Calculation of kinetic constants for hydrolysis of 
cyclic AMP by rat skin PDE. The effect of sub-
strate concentrations on hydrolysis by PDE was 
determined with cyclic AMP concentrations rang-
ing from l0 - 3 to 10- s (Fig. 3). Kinetic data were 
plotted using Lineweaver-Burk plots [23 ], Hofstee 
plots [24], and Dixon plots [25 ]. In Figure 3 two 
apparent Km values are shown on the Lineweaver-
Burk plot. Computer analysis of the linear portion 
of the double reciprocal plots using the least 
squares, linear regression method also gave the 
same results (Fig. 4). Km values of 1.0 x 10- 4 M 
were calculated for the high substrate concentra-
tion PDE activity ("high" Km, Fig. 4b) and 1.7 x 
10- 6 M for the low substrate concentration activ-
ity ("low" Km, Fig. 4a). 
Stimulators and inhibitors of rat skin PDE. -To 
study substrate specificity, cyclic GMP was added 
to the incubation mixture to determine whether it 
significantly changed cyclic AMP hydrolysis. The 
addition of cyclic GMP inhibited cyclic AMP 
hydrolysis at both the high and low cyclic AMP 
substrate concentrations. The low Km PDE was 
competitively inhibited by cyclic GMP (Fig. 5). 
The high Km PDE activity was noncompetitively 
inhibited by cyclic GMP (Fig. 5 inset). The K i of 
cyclic GMP inhibition as determined by Dixon plot 
(Fig. 6) was 1 x 10- 4 M. 
At appropriate concentrations, both the sub-
strate (ATP) and end products (5'-AMP , PPi) of 
the adenyl cyclase-PDE sequence were inhibitory 
for rat skin PDE (Tab. I). In contrast, ADP 
produced no detectable inhibition. Dibutyryl cy-
clic AMP and theophylline were both competi-
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FIG. 2. Enzyme characteristics of rat skin PDE. The 
effects of protein concentration (A , 0.01-0.5 mg/ml) , time 
(B), and pH (C) on the soluble fraction (100,000 x g) of 
rat skin homogenates are shown. The homogenates (0.1 
mg/ml protein) were incubated at 30°C for 10 min in 
Tris- HCl buffer (3.5 mM) containing MgCl 2 (5 mM), 
2-HSE (3.75 mM), . and cyclic AMP (50 J.LM) unless 
otherwise indicated. 
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FIG. 3. Calculation of Michaelis-Menton constants 
(Km) for rat skin PDE. Using cyclic AMP at different 
substrate concentrations under the incubation conditions 
given in Figure 2, two apparent Kms were obtained by 
graphical methods (Lineweaver-Burk plots) for rat skin 
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FIG. 4. High and low cyclic AMP PDE from rat skin. 
Using a linear regression computer method, both high (b) 
and low (a) apparent Km PDE activities were detectable 
in separate experiments on the 100,000 x g supernatant. 
The incubation conditions were the same as in Figure 2 











-10 -5 ~ 10 
I 6 C-AMP)( 10 
O.lmM 
c-GIIP "' Q 
O.OtmM 
c-GMP 
15 20 2~ 
1.~ 
1.0 





FIG. 5. Cyclic GMP effects on the hydrolysis of cyclic 
AMP by rat skin PDE. Lineweaver-Burk plots of rat skin 
PDE against high (inset) and low cyclic AMP concentra-
tions under the same conditions as in Figure 2. Approxi-
mate baseline high and low apparent Km values for cyclic 
AMP are shown (e ). Differential displacement of Km by 
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FIG. 6. Inhibition constant (Ki) for cyclic GMP effect 
on cyclic AMP hydrolysis . Dixon plot of the effects of 
different cyclic GMP concentrations (abscissa) on PDE 
hydrolysis at various cyclic AMP substrate concentra-
tions [S] (ordinate). The apparent inhibition constant 
(Ki) is given. 
tively inhibitory for the low Km PDE (Fig. 7) while 
being noncompetitively inhibitory for the high Km 
PDE (data not shown). Caffeine and theobromine 
were less inhibitory than the theophylline on PDE 
activity at saturating substrate concentrations 
(Tab. I) . 
Maximal PDE activity was obtained in the 
presence of both 2- mercaptoethanol and Mg+ + or 
Mn++ (Tab. I). EDTA was inhibitory for PDE 
activity as was Ca++ even in the presence ofMg++ . 
Co+ +, Cu++, Fe++, Hg++, Pb++, and Zn+ + and the 
anion, F - , were all inhibitory for PDE. Glutaralde-
hyde, the fixative used in the PDE cytochemical 
studies [12], inhibited equally the soluble (Tab. I) 
and the particulate PDE activity (25% residual 
activity) under the same assay conditions. Imid-
azole and histamine phosphate both stimulated 
PDE activity (Tab. I). 
Upon direct incubation of the hormonal agents 
with the-crude enzyme preparations only epineph-
rine produced a consistent inhibitory effect on rat 
skin PDE activity (Tab. II). The polypeptide 
hormones, insulin, ACTH, and glucagon had little 
effect on PDE activity. All the steroid hormones, 
testosterone, triamcinolone, cortisone, and hy-
drocortisone stimulated rat skin PDE. Hydrocorti-
sone phosphate protected the PDE preparations 
from heat denaturation when used in pharmaco-
logic concentrations (Tab. III). 
The bands of PDE activity appeared only after 
incubation with cyclic AMP or cyclic GMP and 
were in the same position when either cyclic 
nucleotide was used at mM concentration (Fig. 8 
inset). When J.LM concentrations of these cy-clic 
nucleotides were used, different bands of activity 
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TABLE I. The effect of different agents on rat skin PDE 
Concen- Percent 
Additions tration of 
(mM) control 
Control 
A. 2-Mercaptoethanol 5.0 40 
(HSE)a 
B. MgCl2 5.0 30 
Heavy Metals 
MgC12 + 2-HSEb 5.0 100 
CaC1 2 5.0 8 
CoSO. 5.0 45 
CuC12 5.0 22 
FeCl2 5.0 1 
HgCl2 5.0 17 
MnC12 5.0 120 
Pb(N0 3 ) 2 5.0 20 
ZnS0 4 5.0 29 
N ucleotides 
ATP 1 45 
10 70 
ADP 1 90 
10 100 
5'-AMP 1 100 
10 30 
PPi 1 50 
db-cyclic AMP 1 71 
Inhibitors, Stimulators, 
Others 
Theophylline 1 41 
10 20 
Caffeine 10 32 
Theobromine 10 40 
Imidazole 10 160 
Histamine phosphate 1 180 
EDTA 1 20 
Na citrate 1 17 
Na fluoride 5.0 60 
Glutaraldehydec 2% 20 
a Reaction mixture included cyclic AMP (50 ~-tM); 
Tris-HCl buffer (3.5 mM), pH 8.0, and was incubated for 
10 min, 30°C [n = 6 ). 
b 2-HSE was added to all reaction mixtures except 
Control B. 
c Glutaraldehyde, 2%, Tris-HCl or cacodylic acid 
buffer, pH 8.0, was preincubated for 30 min with PDE 
homogenates . 
were found, but no variations were found between 
the experimental conditions to account for this 
phenomenon. These differences are being investi-
gated. The tests for PDE specificity and sensitivity 
used by Goren et al [22] (different substrates, 
omission of alkaline phosphatase) showed that the 
PDE preparations used in these gels specifically 
hydrolyzed cyclic AMP or GMP (data not shown). 
In addition, when the 1.5-mm gel slices were 
incubated with cyclic [8- 3H]AMP, the PDE activ-
ity of the individual gel slices corresponded to that 
detected by the activity stain (Fig. 8). 
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FIG. 7. The effects of db-cyclic AMP and theophylline 
on rat skin PDE. Lineweaver- Burk plots of rat skin PDE 
activity against cyclic AMP (b, 50 !J.M) under the same 
conditions as in Figure 2, but in the presence of 1.0 mM 
db-cyclic AMP (0) or theophylline (e ) (n = 6). 
TABLE II. The effect of hormonal agents on rat skin PDE 
Concen - Percent Additions of tration 
control 
Control a 100 
Epinephrine 0.5mM 70 ± 5b 
Insulin 100 !J.U/ml 100 ± 30 
Glucagon 500 .ug/ml 150 ± 16b 
ACTH 20 .uU/ml 90 ± 10 
Testosterone 10 .ug/ml 110 ± 15 
propionate 
Triamcinolone 4 mg/ml 110 ±2b 
diacetatec 
Cortisone acetated 2.5 mg/ml 187 ± lOb 
Hydrocortisone 0.625 mg/ml 130 ± 20b 
Hydrocortisone 0.625 mg/ml 200 ± 40b 
sodium phosphate 
a Reaction mixture included rat skin PDE (0.1 mg/ml 
protein); cyclic AMP (50 !J.M): MgCl 2 (5 mM); 2-mercap-
toethanol (3.75 mM); Tris-HCl buffer (3.5 mM) , pH 8.0, 
and was incubated for 10 min, 30°C (n = 6; b p < .001) . 
c Aristocort Forte, Lederle, 40 mg/ml. 
d Cortisone acetate, USP, Upjohn, 25 mg/ml. 
e Hydrocortone, Merck, Sharp, and Dohme. 
DISCUSSION 
PDE has been detected in almost all mamma-
lian tissues examined [4,5, 18 ]. The highest total 
activity has been found in the brain where regional 
differences occur [4 ]. By comparison, rat skin 
Vol. 64, No. 6 
PDE, as reported here, contains 10% of the PDE 
activity of similar preparations from rat brain and 
similar activity to that found in mouse epidermis 
[10]. Depending upon the tissue and method of 
preparation, multiple forms of PDE are usually 
detected by kinetic analysis [18 ]. Using the par-
tially purified rat epidermis we have also found a 
high Km (100 ~M) and low Km (2 ~M) PDE (Fig . 
4a,b). These apparent Kms are comparable to those 
found in other rat tissues [18) and mouse skin [10]. 
Like most other tissues, the PDE activity of rat 
(Fig. 1), mouse [9,10], and human skin [9] is found 
in both the particulate and soluble forms. Most 
studies on PDE have investigated the soluble 
forms and largely ignored the particulate associ-
ated PDE [18 ,26 ]. The structural and/or functional 
relationships between the soluble and particulate 
PDE or their relationships to the two kinetic forms 
("high," "low") are not known. In rat skin we 
found PDE activity to be membrane-associated in 
all cell types studied by a cytochemical method 
[12 ]. Using the gel staining method of Goren et al 
[22] we found that the 100,000 x g supernatant we 
used contained at least two distinct protein bands 
that hydrolyze cyclic AMP. Also, hydrocortisone 
phosphate appeared to stabilize and activate the 
high Km form of PDE in these 100,000 X g 
supernatants without affecting the low Km form 
(King, unpublished observations). Work is in prog-
ress using these techniques to define the interrela-
tionships among the different forms of PDE. 
There are several other features of rat skin PDE 
that appear to differ from mouse epidermal PDE 
[10]. Marks and Raab found that in mouse epider-
mis: (1) the PDE activity was almost exclusively 
associated with the 17,000 x g supernatant; (2) 
NaF inhibits and histamine stimulates rat epider-
mal PDE and the PDEs of other rat tissues [18 ], 
but they have no effect on mouse skin PDE; (3) 
cyclic GMP interferes with cyclic AMP hydrolysis 
by PDE in the skin and other tissues of the rat [18], 
but this interference did not occur with mouse 
epidermal PDE [10). Although we found no sub-
strate inhibition by 5' -AMP at concentrations up 
to 5 mM as did Marks and Raab, we found that at 
10 mM 5' -AMP inhibited the rat epidermal PDE as 
it did other rat tissues [4,18 ]. All of these differ-
ences between the two studies could have been due 
to ,species difference or to the different methods 
used in preparing and assaying PDE. Kinetic 
determinations on PDE activity are important and 
were helpful in correlating the changes in the 
intracellular concentrations of cyclic AMP with 
growth rate, differentiation, and hormonal and 
immune responses [27-33 ]. For example, differ-
ences in Km or molecular forms were found in 
animal models of human diseases (neoplasia, 
27-28; hypertension, 29; obesity, 30; visual defects, 
31). In skin, specific mechanisms to control the 
synthesis or activity of PDE have not been identi-
fied. Similarly, almost no changes in the total PDE 
activity have been detected that could explain the 
differences in the cyclic nucleotide levels in normal 
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TABLE III. The effects of hydrocortisone on the heat denaturation of rat skin PDE 
Additions Concentration %of Control 
Preincubation temperatures 
60°C I 80°C I 100°C 
% Activity 
Control a 100 0 0 
Hydrocortisone sodium 0.0625 mg/ml 130 0 0 
phosphateb 
0.625 mg/ml 240 200 0 
6.25 mg/ml 1800 1900 2000 
a Reaction mixture included cyclic AMP (50 }.LM), MgCl 2 (5 mM), 2-mercaptoethanol (3.75 mM), Tris-HCl buffer 
(3.5 mM), pH 8.0, and was incubated for 10 min, 30°C, with 0.1 ml rat skin homogenate which had been preincubated 
with hydrocortisone phosphate for 3 min at the temperatures listed above. 
b Hydrocortone , Merck, Sharp, and Dohme. 
10 20 30 40 50 
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FIG. 8. Detection of PDE activity after gel electropho-
resis. Rat epidermal PDE (100,000 x g supema.tant) w~s 
subjected to polyacrylamide gel electrophore~1s . Dupl~­
cate gels were either stained using a coupled histocheJ?I-
cal method (inset) or cut into 1.5-mm shces to determme 
PDE activity by the two-step radioisotopic assay method. 
The reaction mixture given in Figure 2 was incubated for 
30 min with the gels. An additional incubation step with 
5% ammonium sulfide was used to produce the black 
precipitate. 
or diseased human skin. In contrast, a defective 
adenyl cyclase activity has been reported in psoria-
sis [7] although a concomitant decrease in cyclic 
AMP and an increase in cyclic GMP without any 
changes in adenyl cyclase or the high Km PDE also 
were reported [8 ]. Therefore, more work on eluci-
dating the specific role of PDE in the epidermis 
must be done before its function(s) can be under-
stood. More recently, Voorhees et al [34] report 
that they are now able to detect a difference in 
PDE activity in psoriatic skin when using more 
sensitive assay techniques. 
The authors wish to acknowledge the excellent techni-
cal assistance of Ms. M. Palazzolo. 
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